Target intelligence / Profile preview

Phosphatidylinositol 4,5-bisphosphate (PIP2) (PIP2)

Target
PIP2
Molecular classification
Phospholipid, Signaling lipid, Second messenger
01

Overview

Phosphatidylinositol 4,5-bisphosphate (PIP2) is a minor but functionally critical phospholipid component of eukaryotic cell membranes that serves as a key signaling scaffold and a precursor to several intracellular second messengers (Balla, 2013). It is cleaved by phospholipase C to generate inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG), and phosphorylated by PI3K to produce PIP3, all of which are vital for signal transduction (Di Paolo & De Camilli, 2006). Beyond its role as a precursor, PIP2 directly regulates the activity of numerous ion channels, transporters, and proteins involved in actin cytoskeleton remodeling and vesicular trafficking (McLaughlin et al., 2002). Dysregulation of phosphoinositide metabolism is a central feature in many human pathologies, including cancer, where the PI3K/AKT/mTOR pathway is frequently hyperactivated, and various genetic disorders like Lowe syndrome (Suh & Hille, 2008). Therapeutic strategies include the use of small molecules that sequester these lipids, such as certain aminoglycosides, or more commonly, inhibitors of the kinases and phosphatases that regulate their interconversion (Gabev et al., 1989). Because phosphoinositides are fundamental to basic cellular homeostasis across all tissues, targeting them directly presents significant challenges regarding the therapeutic index and potential for systemic toxicity (Balla, 2013).

Other names
PtdIns(4,5)P2Phosphatidylinositol 4,5-bisphosphatePhosphoinositidesPolyphosphoinositidesPhosphatidylinositol phosphates
02

Mechanism of action

Direct binding and sequestration of phosphoinositides, inhibition of downstream signaling cascades by blocking lipid-protein interactions, or modulation of membrane lipid composition.

03

Biological functions

Signal transductionMembrane traffickingCytoskeletal organizationIon channel regulationNuclear signaling
04

Disease associations

CancerDiabetes mellitusNeurological disordersLowe syndromeInflammation
05

Safety considerations

Broad systemic toxicityDisruption of essential cellular homeostasisPotential for neurological and renal side effects
06

Interacting drugs

Neomycin

3 more in the full profile.

07

Biomarkers

PIP3 levelsPTEN expression levelsAKT phosphorylation status

Beyond the preview

Go deeper on Phosphatidylinositol 4,5-bisphosphate (PIP2) (PIP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phosphatidylinositol 4,5-bisphosphate (PIP2) (PIP2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call